Because β-adrenoceptor agonists can influence glucose homeostasis by modulating insulin secretion, liver metabolism, and uptake of glucose into muscle [25], these results could be partly explained by poorly controlled diabetes, which would increase the risk of PD. The gene discussed is INS; the disease is Parkinson disease.